Evidence map›Paper›PMID 32454041›Full record

ArticleJournal of hepatology2020

An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.

Claire Alexandra Chew, Shridhar Ganpathi Iyer, Alfred Wei Chieh Kow, Krishnakumar Madhavan, Andrea Sze Teng Wong, Karim J Halazun, Narendra Battula, Irene Scalera, Roberta Angelico, Shahid Farid and 14 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. COVID-19 and the liver: What do we know so far?World journal of hepatology · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Impact of COVID-19 in solid organ transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Review
  13. COVID 19 and liver: An A-Z literature review.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2021
    Review
  14. Article
  15. Review
  16. Overview of Complications in Cirrhosis.Journal of clinical and experimental hepatology
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Claire Alexandra ChewNational University Hospital, Singapore.
Shridhar Ganpathi IyerNational University Hospital, Singapore.
Alfred Wei Chieh KowNational University Hospital, Singapore.
Krishnakumar MadhavanNational University Hospital, Singapore.
Andrea Sze Teng WongArchitectural Association School of Architecture, London, United Kingdom.
Karim J HalazunWeill Cornell Medicine, New York, United States.
Narendra BattulaUniversity of Florida Health, Florida, United States.
Irene ScaleraCardarelli Hospital, Naples, Italy.
Roberta AngelicoUniversity of Rome Tor Vegata, Rome, Italy.
Shahid FaridSt James University Hospital, Leeds, United Kingdom.
Bettina M BuchholzUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fernando RotellarClinica Universidad de Navarra, Pamplona, Spain.
Albert Chi-Yan ChanQueen Mary Hospital, Hong Kong.
Jong Man KimSamsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea.
Chih-Chi WangKaohsiung Chang Gung Memorial Hospital, Taiwan.
Maheswaran PitchaimuthuKovai Medical Center and Hospital, Coimbatore, India.
Mettu Srinivas ReddyDr. Rela Institute & Medical Centre, Chennai, India.
Arvinder Singh SoinMedanta the Medicity, Gurgaon, India.
Carlos DerosasClínica Santa Maria, Chile.
Oscar ImventarzaHospital Argerich, Buenos Aires, Argentina; Hospital Garrahan, Buenos Aires, Argentina.
John IsaacUniversity Hospitals Birmingham, Birmingham, United Kingdom.
Paolo MuiesanUniversity Hospitals Birmingham, Birmingham, United Kingdom.
Darius F MirzaUniversity Hospitals Birmingham, Birmingham, United Kingdom.
Glenn Kunnath BonneyNational University Hospital, Singapore; SurgiCAL ProtEomics Laboratory, National University of Singapore, Singapore. Electronic address: glenn_bonney@nuhs.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsThe outbreak of COVID-19 has vastly increased the operational burden on healthcare systems worldwide. For patients with end-stage liver failure, liver transplantation is the only option. However, the strain on intensive care facilities caused by the pandemic is a major concern. There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources.

methodsWe performed an international multicenter study of transplant centers to understand the evolution of policies for transplant prioritization in response to the pandemic in March 2020. To describe the ethical tension arising in this setting, we propose a novel ethical framework, the quadripartite equipoise (QE) score, that is applicable to liver transplantation in the context of limited national resources.

resultsSeventeen large- and medium-sized liver transplant centers from 12 countries across 4 continents participated. Ten centers opted to limit transplant activity in response to the pandemic, favoring a "sickest-first" approach. Conversely, some larger centers opted to continue routine transplant activity in order to balance waiting list mortality. To model these and other ethical tensions, we computed a QE score using 4 factors - recipient outcome, donor/graft safety, waiting list mortality and healthcare resources - for 7 countries. The fluctuation of the QE score over time accurately reflects the dynamic changes in the ethical tensions surrounding transplant activity in a pandemic.

conclusionsThis four-dimensional model of quadripartite equipoise addresses the ethical tensions in the current pandemic. It serves as a universally applicable framework to guide regulation of transplant activity in response to the increasing burden on healthcare systems. LAY SUMMARY: There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources during the COVID-19 pandemic. We describe a four-dimensional model of quadripartite equipoise that models these ethical tensions and can guide the regulation of transplant activity in response to the increasing burden on healthcare systems.

Indexed as

End Stage Liver DiseaseLiver TransplantationPandemicsTissue and Organ ProcurementBetacoronavirusCoronavirus InfectionsCOVID-19Health ResourcesHumansInternational CooperationOrganizational InnovationPatient SelectionPneumonia, ViralSARS-CoV-2Surveys and QuestionnairesWaiting ListsCOVID-19EquipoiseEthicsLiver transplantation

Identifiers

PMID32454041
PMCPMC7245234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.